OBJECTIVE: To study the effect of nimodipine on hippocampal regional cerebral blood flow (rCBF) and proinflammatory cytokines in rats with experimental vascular dementia. METHODS: Male Sprague Dawley rats were randomly divided into four groups (n = 15/group): sham operated controls (group A); focal cerebral ischaemia (group B); vascular dementia (group C); and vascular dementia treated with 20 mg/kg nimodipine daily (group D). The Morris water maze test evaluated learning and memory, and magnetic resonance perfusion-weighted imaging was used to measure rCBF. Hippocampal levels of nuclear factor-κB (NF-κB), tumour necrosis factor-α (TNF-α) and interleukin 1β (IL-1β) were measured. RESULTS: Compared with group C, rats in group D demonstrated significantly improved learning ability and significantly increased hippocampal rCBF. The levels of NF-κB, TNF-α and IL-1β were significantly lower in group D than in group C. Hippocampal nerve cell morphology was abnormal in group C but near normal in group D. CONCLUSIONS: Nimodipine improved the symptoms of cognitive impairment, increased rCBF, reduced hippocampal cytokine levels and alleviated neuronal injury in the hippocampus of rats with experimental vascular dementia.
LüdersSStöveSSchraderJ: Prevention of vascular dementia. Evidence and practice. Internist (Berl)2012; 53: 223–231 [in German, English abstract].
2.
YagamiT: Cerebral arachidonate cascade in dementia: Alzheimer's disease and vascular dementia. Curr Neuropharmacol2006; 4: 87–100.
3.
ZhangBWuHQZhangHX: Neurobiochemical mechanisms of vascular dementia. Foreign Medical Sciences (Cerebrovascular Diseases)2005; 13: 672–675 [in Chinese].
4.
JonesCRHileyCRPeltonJT: Autoradiographic visualization of the binding sites for [125I]endothelin in rat and human brain. Neurosci Lett1989; 97: 276–279.
5.
MinDMaoXWuK: Donepezil attenuates hippocampal neuronal damage and cognitive deficits after global cerebral ischemia in gerbils. Neurosci Lett2012; 510: 29–33.
6.
ZekryDDuyckaertsCBelminJ: The vascular lesions in vascular and mixed dementia: the weight of functional neuroanatomy. Neurobiol Aging2003; 24: 213–219.
7.
AngelopoulosPAgouridakiHVaiopoulosH: Cytokines in Alzheimer's disease and vascular dementia. Int J Neurosci2008; 118: 1659–1672.
8.
RosenbergGA: Inflammation and white matter damage in vascular cognitive impairment. Stroke2009; 40 (3 suppl): S20–S23.
9.
TrollorJNSmithEBauneBT: Systemic inflammation is associated with MCI and its subtypes: the Sydney Memory and Aging Study. Dement Geriatr Cogn Disord2010; 30: 569–578.
10.
BattiLO'ConnorJJ: Tumor necrosis factor-α impairs the recovery of synaptic transmission from hypoxia in rat hippocampal slices. J Neuroimmunol2010; 218: 21–27.
11.
ZulianiGRanziniMGuerraG: Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia. J Psychiatr Res2007; 41: 686–693.
12.
PennisiGFerriRCantoneM: A review of transcranial magnetic stimulation in vascular dementia. Dement Geriatr Cogn Disord2011; 31: 71–80.
13.
CohenRA: Hypertension and cerebral blood flow: implications for the development of vascular cognitive impairment in the elderly. Stroke2007; 38: 1715–1717.
14.
IadecolaC: The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol2010; 120: 287–296.
15.
BennettSGrantMMAldredS: Oxidative stress in vascular dementia and Alzheimer's disease: A common pathology. J Alzheimers Dis2009; 17: 245–257.
16.
KirvellSLElliottMSKalariaRN: Vesicular glutamate transporter and cognition in stroke: A case—control autopsy study. Neurology2010; 75: 1803–1809.
17.
ZhangHZZhangLXSheYF: Effect of electroacupuncture on apoptosis of hippocampus tissue in mice with vascular dementia. Zhen Ci Yan Jiu2008; 33: 377–381 [in Chinese, English abstract].
LockmanJAGeldenhuysWJBohnKA: Differential effect of nimodipine in attenuating iron-induced toxicity in brain- and blood—brain barrier-associated cell types. Neurochem Res2012; 37: 134–142.
20.
BekkerAHaileMLiYS: Nimodipine prevents memory impairment caused by nitroglycerin-induced hypotension in adult mice. Anesth Analg2009; 109: 1943–1948.
21.
LindsayRWHeatonJTEdwardsC: Nimodipine and acceleration of functional recovery of the facial nerve after crush injury. Arch Facial Plast Surg2010; 12: 49–52.
22.
AslanAGurelikMCemekM: Nimodipine can improve cerebral metabolism and outcome in patients with severe head trauma. Pharmacol Res2009; 59: 120–124.
23.
PantoniLdel SerTSoglianAG: Efficacy and safety of nimodipine in subcortical vascular dementia: A randomized placebo-controlled trial. Stroke2005; 36: 619–624.
24.
O'BrienJTBurnsA, BAP Dementia Consensus Group: Clinical practice with anti-dementia drugs: A revised (second) consensus statement from the British Association for Psychopharmacology. J Psychopharmacol2011; 25: 997–1019.
25.
DoodyRSStevensJCBeckC: Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology2001; 56: 1154–1166.
26.
ChoiSKLeeGJChoiS: Neuroprotective effects by nimodipine treatment in the experimental global ischemic rat model: real time estimation of glutamate. J Korean Neurosurg Soc2011; 49: 1–7.
27.
YanpallewarSUHotaDRaiS: Nimodipine attenuates biochemical, behavioral and histopathological alterations induced by acute transient and long-term bilateral common carotid occlusion in rats. Pharmacol Res2004; 49: 143–150.
28.
MaBZhangJ: Nimodipine treatment to assess a modified mouse model of intracerebral hemorrhage. Brain Res2006; 1078: 182–188.
29.
Animal Care and Use Committee: Guidelines for the capture, handling, and care of mammals as approved by the American Society of Mammalogists. J Mammal1988; 79: 1416–1431.
30.
LongaEZWeinsteinPRCarlsonS: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke1989; 20: 84–91.
31.
MorrisR: Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods1984; 11: 47–60.
32.
HaileMLimsonFGingrichK: Nimodipine prevents transient cognitive dysfunction after moderate hypoxia in adult mice. J Neurosurg Anesthesiol2009; 21: 140–144.
33.
LiYHuXLiuY: Nimodipine protects dopaminergic neurons against inflammation-mediated degeneration through inhibition of microglial activation. Neuropharmacology2009; 56: 580–589.
34.
TerrandoNErikssonLIRyuJ Kyu: Resolving postoperative neuroinflammation and cognitive decline. Ann Neurol2011; 70: 986–995.
35.
NishioKIharaMYamasakiN: A mouse model characterizing features of vascular dementia with hippocampal atrophy. Stroke2010; 41: 1278–1284.
36.
ErdemAFCesurMAliciHA: Effects of sevoflurane and desflurane in CA1 after incomplete cerebral ischemia in rats. Saudi Med J2005; 26: 1424–1428.
37.
SeguinJABrennanJManganoE: Proinflammatory cytokines differentially influence adult hippocampal cell proliferation depending upon the route and chronicity of administration. Neuropsychiatr Dis Treat2009; 5: 5–14.
38.
YangSYWangZG: Therapeutic effect of nimodipine on experimental brain injury. Chin J Traumatol2003; 6: 326–331.
